Development of an improved vaccine for anthrax

Journal of Clinical Investigation

Volumn 110, Issue 2, 2002, Pages 141-144

  Leppla, Stephen H ^a   Robbins, John B ^b   Schneerson, Rachel ^b   Shiloach, Joseph ^c  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE; AVA; UNCLASSIFIED DRUG;

ANTHRAX; BACILLUS ANTHRACIS; BACTERIAL IMMUNITY; FOOD AND DRUG ADMINISTRATION; IMMUNIZATION; PRIORITY JOURNAL; REVIEW;

EID: 0036076991     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0216204     Document Type: Review

References (35)

1. Large-scale production of protective antigen of Bacillus anthracis in anaerobic cultures
2. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity
3. Field evaluation of a human anthrax vaccine
4. Biological products: Bacterial vaccines and toxoids; implementation of efficacy review. Proposed rule
5. Studies on immunity in anthrax. V. Immunizing activity of alum-precipitated protective antigen
6. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin
7. Studies on immunity in anthrax. X. Gel-adsorbed protective antigen for immunization of man
8. Anthrax vaccine: Increasing intervals between the first two doses enhances antibody response in humans
9. Demonstration of a capsule plasmid in Bacillus anthracis
10. Virulence and immunogenicity in experimental animals of Bacillus anthracis strains harbouring or lacking 110 MDa and 60 MDa plasmids
11. The bifactorial Bacillus anthracis lethal and oedema toxins
12. Seven toxin peptides that cross cell membranes
13. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin
14. Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells
15. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor
16. Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin
17. Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis
18. Non-toxigenic derivatives of the Ames strain of Bacillus anthracis are fully virulent for mice: Role of plasmid pX02 and chromosome in strain-dependent virulence
19. In vitro correlate of immunity in a rabbit model of inhalational anthrax
20. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein
21. A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned
22. On the role of macrophages in anthrax
23. Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies
24. A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection
25. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity
26. Immunochemical studies on the poly-gamma-D-glutamyl capsule of Bacillus anthracis. I. Characterization of the polypeptide and of the specificity of its reaction with rabbit antisera
27. Anthrax spores make an essential contribution to vaccine efficacy
28. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores
29. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax
30. Anthrax vaccine: Evidence for safety and efficacy against inhalational anthrax
31. Protein explorer: Easy yet powerful macromolecular visualization